In Case You Missed It: News On Decentralized Trials, Drug Safety, And More
Executive Summary
We clean out your President’s Day inbox so you don’t have to.
Many readers in the US enjoyed a holiday on Monday, but our experts in the states and around the world still offered up insights. Here are the stories that went out in Monday’s email in case you missed them:
Denmark Tackles ‘All Talk And No Action’ On Decentralized Clinical Trials
EMA Starts Rolling Review Of CureVac’s COVID-19 Vaccine
EMA To Advise On Tweaking COVID-19 Vaccines Due To New Variants
Incorrect Use Of Reference Safety Info Still An Issue, Says UK MHRA
Amicus Pompe Disease Combo’s Approvability In Question As Key Trial Misses Mark
Veklury Gets EMA All-Clear Over Kidney Problems, But Faces New Safety Review For Bradycardia